Importantly, TPX2 acts as an oncogenic protein and upregulates the expression of matrix metalloproteases (MMPs) through activation of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway in colon cancer [12]. The gene discussed is TPX2; the disease is malignant colon neoplasm.